GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Sign Up For Our Newsletter

News Articles: major depression

Root extracts from the African shrub iboga have long been used in traditional healing rituals and more recently as an experimental treatment for depression and to reduce drug cravings in addiction. Scientists now are working on a version of the extract that doesn't cause heart attacks or hallucinations as side effects.

Progress Toward A Safer Psychedelic Drug To Treat Depression And Addiction

A synthetic version of the psychedelic drug ibogaine appears to relieve depression and addiction without producing hallucinations or other dangerous side effects — at least in rodents.

|
By:
  • Jon Hamilton
The hallucinogenic chemical psilocybin produced in some mushrooms helped people with major depression in a study that also included supportive psychotherapy.

Rigorous Study Backs A Psychedelic Treatment For Major Depression

Psilocybin, the hallucinogenic substance found in "magic" mushrooms, appears to relieve the symptoms of major depression.

|
By:
  • Jon Hamilton
In 2019, the FDA approved Spravato for patients with major depressive disorder who hadn't responded to other treatments. Now, the agency is adding patients who are having suicidal thoughts or have recently attempted to harm themselves or take their own lives.

Nasal Spray Is A New Antidepressant Option For People At High Risk of Suicide

Doctors have a new option for suicidal patients. It's a fast-acting nasal spray containing a version of the anesthetic ketamine.

|
By:
  • Jon Hamilton